<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; Ovarian</title>
	<atom:link href="http://www.canadiannetmall.com/blog/tag/ovarian/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Slowing Ovarian Tumor Growth With Dipththeria Toxin DNA</title>
		<link>http://www.canadiannetmall.com/blog/slowing-ovarian-tumor-growth-with-dipththeria-toxin-dna/</link>
		<comments>http://www.canadiannetmall.com/blog/slowing-ovarian-tumor-growth-with-dipththeria-toxin-dna/#comments</comments>
		<pubDate>Fri, 08 Jan 2010 17:06:40 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Women's health]]></category>
		<category><![CDATA[Ovarian]]></category>
		<category><![CDATA[ovarian tumor]]></category>
		<category><![CDATA[paclitaxel]]></category>
		<category><![CDATA[Taxol]]></category>
		<category><![CDATA[treatment ovarian]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2656</guid>
		<description><![CDATA[A new technique for reducing the burden of ovarian tumors in mice might be available for testing in humans within 18 to 24 months. Although early-stage ovarian cancer sometimes responds to surgery followed by chemotherapy, there are no effective treatments for advanced ovarian cancer that has recurred after surgery and primary chemotherapy. Therefore, most treated [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/slowing-ovarian-tumor-growth-with-dipththeria-toxin-dna/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>OVAI, a Test for Ovarian Cancer</title>
		<link>http://www.canadiannetmall.com/blog/ovai-a-test-for-ovarian-cancer/</link>
		<comments>http://www.canadiannetmall.com/blog/ovai-a-test-for-ovarian-cancer/#comments</comments>
		<pubDate>Sat, 12 Dec 2009 14:02:44 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Generic OVA1]]></category>
		<category><![CDATA[oncologist]]></category>
		<category><![CDATA[OVA1]]></category>
		<category><![CDATA[OVA1 drug]]></category>
		<category><![CDATA[Ovarian]]></category>
		<category><![CDATA[test]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2561</guid>
		<description><![CDATA[A new test, called OVA1 (Vermillion, Inc.), can help detect ovarian cancer in a pelvic mass. OVA1 drug identifies some women who will benefit from referral to a gynecological oncologist for surgery despite negative results from other tests for ovarian cancer. If other test results suggest cancer, referral to an oncologist is appropriate even with [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/ovai-a-test-for-ovarian-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

